Cortisone and ACTH in hypoplastic anemia.
作者信息
ERSLEV A J, IVERSON C K, LAWRASON F D
出版信息
Yale J Biol Med. 1952 Sep;25(1):44-50.
Abstract
摘要
相似文献
1
Cortisone and ACTH in hypoplastic anemia.可的松与促肾上腺皮质激素治疗再生障碍性贫血。
Yale J Biol Med. 1952 Sep;25(1):44-50.
2
[Effect of the treatment of aplastic conditions with cortisone and ACTH].[用可的松和促肾上腺皮质激素治疗再生障碍性疾病的效果]
Pol Arch Med Wewn. 1956;26(9):1375-80.
3
ACTH and cortisone in the treatment of the aplastic and adynamic anemias.
Bull New Engl Med Cent. 1951 Dec;13(6):252-63.
4
5
The physiologic evaluation and management of chronic bone marrow failure.慢性骨髓衰竭的生理学评估与管理
Am J Med. 1953 Oct;15(4):499-517. doi: 10.1016/0002-9343(53)90140-5.
6
[Effective continuous cortisone and ACTH therapy of a case of erythroblastophthisis of Diamond-Blackfan type].[对一例钻石-布莱克范型成红细胞贫血症进行有效的连续皮质酮和促肾上腺皮质激素治疗]
Arztl Wochensch. 1955 Mar 4;10(9):208-10.
7
[ACTH and cortisone therapy of acquired hemolytic anemia].[促肾上腺皮质激素和可的松治疗获得性溶血性贫血]
Ugeskr Laeger. 1953 Jul 23;115(30):1139-44.
8
9
ACTH and cortisone in the treatment of sickle-cell anemia; report of a case.促肾上腺皮质激素和可的松治疗镰状细胞贫血；一例报告
N Engl J Med. 1952 Apr 10;246(15):583-4. doi: 10.1056/NEJM195204102461505.
10
Idiopathic acquired hemolytic anemia treated by ACTH and cortisone.促肾上腺皮质激素和可的松治疗特发性获得性溶血性贫血。
Ann Intern Med. 1952 Apr;36(4):1106-11. doi: 10.7326/0003-4819-36-4-1106.
引用本文的文献
1
The glucocorticoid receptor elicited proliferative response in human erythropoiesis is BCL11A-dependent.糖皮质激素受体在人类红细胞生成中引发的增殖反应依赖于 BCL11A。
Stem Cells. 2024 Nov 5;42(11):1006-1022. doi: 10.1093/stmcls/sxae049.
2
Aplastic anemia in Shiraz, an analysis of 50 cases with special reference to etiological agents in Southwest Iran.设拉子的再生障碍性贫血：对50例病例的分析，特别提及伊朗西南部的病因
Blut. 1973 Jan;26(1):20-6. doi: 10.1007/BF01631307.
本文引用的文献
1
The clinical usefulness of ACTH and cortisone.促肾上腺皮质激素和可的松的临床效用。
N Engl J Med. 1950 Jun 1;242(22):865-72. doi: 10.1056/NEJM195006012422205.
2
The clinical usefulness of ACTH and cortisone.促肾上腺皮质激素和可的松的临床效用。
N Engl J Med. 1950 May 25;242(21):824-34; contd. doi: 10.1056/NEJM195005252422105.
3
Hematologic changes with ACTH and cortisone therapy of rheumatoid arthritis.促肾上腺皮质激素和可的松治疗类风湿关节炎的血液学变化。
Blood. 1951 Nov;6(11):1034-50.
4
Effect of corticotrophin and cortisone on the blood in various disorders in man.促肾上腺皮质激素和可的松对人类各种疾病血液的影响。
AMA Arch Intern Med. 1951 Sep;88(3):310-36. doi: 10.1001/archinte.1951.03810090041004.
5
Clinical evaluation of corticotropin therapy.促肾上腺皮质激素疗法的临床评估。
AMA Arch Intern Med. 1951 Aug;88(2):211-34. doi: 10.1001/archinte.1951.03810080079009.
6
The treatment of acquired hemolytic anemia with adrenocorticotrophic hormone (ACTH).用促肾上腺皮质激素（ACTH）治疗获得性溶血性贫血。
N Engl J Med. 1951 Jan 25;244(4):117-27. doi: 10.1056/NEJM195101252440401.
7
Use of pituitary adrenocorticotropic hormone (ACTH) and cortisone in lymphomas and leukemias.垂体促肾上腺皮质激素（ACTH）和可的松在淋巴瘤及白血病中的应用。
J Am Med Assoc. 1950 Dec 16;144(16):1349-53. doi: 10.1001/jama.1950.02920160023005.
8
Effect of cortisone and pituitary adrenocorticotropic hormone (ACTH) on rheumatic diseases.可的松和垂体促肾上腺皮质激素（ACTH）对风湿性疾病的影响。
J Am Med Assoc. 1950 Dec 16;144(16):1327-35. doi: 10.1001/jama.1950.02920160001001.
Zotero 插件